Biological Networks in Ischemic Tolerance - Rethinking the Approach to Clinical Conditioning

Translational Stroke Research

Volumn 4, Issue 1, 2013, Pages 114-129

  Anrather, Josef ^a   Hallenbeck, John M ^b  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cerebral ischemia; Humoral factors; Ischemic tolerance; Neural circuits; Postconditioning; Preconditioning; Remote preconditioning; Stroke; Stroke therapy

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ADENOSINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; HUMORAL ANTIBODY; KININOGEN; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; OPIATE; OPIATE RECEPTOR; REACTIVE OXYGEN METABOLITE; SEVOFLURANE; XANTHINE OXIDASE;

BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN PROTECTION; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; ENVIRONMENTAL STRESS; HEART PROTECTION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MESENTERIC ARTERY; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TRANSLATIONAL RESEARCH;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN; BRAIN ISCHEMIA; CLINICAL PROTOCOLS; FEMALE; HUMANS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; RABBITS; RATS;

EID: 84872661839     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0244-z     Document Type: Review

References (174)

1. Yenari M, Kitagawa K, Lyden P, Perez-Pinzon M. Metabolic downregulation: A key to successful neuroprotection? Stroke. 2008; 39: 2910-7.
2. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: From experimental strategies to clinical use. Lancet Neurol. 2009; 8: 398-412.
3. + channels and their role in cardioprotection. Circ Res. 2004; 94: 420-32.
4. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci. 2006; 7: 437-48.
5. Zhao H. The protective effect of ischemic postconditioning against ischemic injury: From the heart to the brain. J Neuroimmune Pharmacol. 2007; 2: 313-8.
6. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010; 87: 406-23.
7. Perez-Pinzon MA, Stetler RA, Fiskum G. Novel mitochondrial targets for neuroprotection. J Cereb Blood Flow Metab. 2012; 32: 1362-76.
8. Calabrese EJ. Converging concepts: Adaptive response, preconditioning, and the Yerkes-Dodson law are manifestations of hormesis. Ageing Res Rev. 2008; 7: 8-20.
9. Mattson MP. Hormesis defined. Ageing Res Rev. 2008; 7: 1-7.
10. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993; 87: 893-9.
11. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 1996; 94: 2193-200.
12. Bolte CS, Liao S, Gross GJ, Schultz Jel J. Remote preconditioning-endocrine factors in organ protection against ischemic injury. Endocr Metab Immune Disord Drug Targets. 2007; 7: 167-75.
13. Pang CY, Forrest CR, Mounsey R. Pharmacologic intervention in ischemia-induced reperfusion injury in the skeletal muscle. Microsurgery. 1993; 14: 176-82.
14. Kadambi A, Skalak TC. Role of leukocytes and tissue-derived oxidants in short-term skeletal muscle ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2000; 278: H435-43.
15. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 2001; 103: 1624-30.
16. Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem. 2010; 113: 1685-91.
17. Lee ST, Chu K, Jung KH, Yoon HJ, Jeon D, Kang KM, et al. MicroRNAs induced during ischemic preconditioning. Stroke. 2010; 41: 1646-51.
18. Lusardi TA, Farr CD, Faulkner CL, Pignataro G, Yang T, Lan J, et al. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J Cereb Blood Flow Metab. 2010; 30: 744-56.
19. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11: 597-610.
20. Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: Approaches and considerations. Nat Rev Genet. 2012; 13: 358-69.
21. Huda R, Chung DH, Mathru M. Ischemic preconditioning at a distance: Altered gene expression in mouse heart and other organs following brief occlusion of the mesenteric artery. Heart Lung Circ. 2005; 14: 36-43.
22. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, Gysembergh A, et al. Rabbit heart can be "preconditioned" via transfer of coronary effluent. Am J Physiol. 1999; 277: H2451-7.
23. Hu S, Dong H, Zhang H, Wang S, Hou L, Chen S, et al. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res. 2012; 1459: 81-90.
24. Zhao HG, Sun XC, Xian XH, Li WB, Zhang M, Li QJ. The role of nitric oxide in the neuroprotection of limb ischemic preconditioning in rats. Neurochem Res. 2007; 32: 1919-26.
25. Rehni AK, Singh N, Jaggi AS. Possible involvement of insulin, endogenous opioids and calcitonin gene-related peptide in remote ischaemic preconditioning of the brain. Yakugaku Zasshi. 2007; 127: 1013-20.
26. Vlasov TD, Korzhevskii DE, Polyakova EA. Ischemic preconditioning of the rat brain as a method of endothelial protection from ischemic/repercussion injury. Neurosci Behav Physiol. 2005; 35: 567-72.
27. Dong H-L, Zhang Y, Su B-X, Zhu Z-H, Gu Q-H, Sang H-F, et al. Limb remote ischemic preconditioning protects the spinal cord from ischemia-reperfusion injury: A newly identified nonneuronal but reactive oxygen species-dependent pathway. Anesthesiology. 2010; 112: 881-91.
28. Zhou Y, Fathali N, Lekic T, Ostrowski RP, Chen C, Martin RD, et al. Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke. 2011; 42: 439-44.
29. Iadecola C, Kahles T, Gallo EF, Anrather J. Neurovascular protection by ischaemic tolerance: Role of nitric oxide. J Physiol (Lond). 2011; 589: 4137-45.
30. Muller B, Kleschyov AL, Alencar JL, Vanin A, Stoclet JC. Nitric oxide transport and storage in the cardiovascular system. Ann N Y Acad Sci. 2002; 962: 131-9.
31. Steensrud T, Li J, Dai X, Manlhiot C, Kharbanda RK, Tropak M, et al. Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine. Am J Physiol Heart Circ Physiol. 2010; 299: H1598-603.
32. Liem DA, Verdouw PD, Ploeg H, Kazim S, Duncker DJ. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol. 2002; 283: H29-37.
33. Costa F, Sulur P, Angel M, Cavalcante J, Haile V, Christman B, et al. Intravascular source of adenosine during forearm ischemia in humans: Implications for reactive hyperemia. Hypertension. 1999; 33: 1453-7.
34. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 1989; 256: C799-806.
35. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol. 2000; 278: H1571-6.
36. Jones WK, Fan G-C, Liao S, Zhang J-M, Wang Y, Weintraub NL, et al. Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling. Circulation. 2009; 120: S1-9.
37. Dickson EW, Blehar DJ, Carraway RE, Heard SO, Steinberg G, Przyklenk K. Naloxone blocks transferred preconditioning in isolated rabbit hearts. J Mol Cell Cardiol. 2001; 33: 1751-6.
38. Zhang SZ, Wang NF, Xu J, Gao Q, Lin GH, Bruce IC, et al. Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology. 2006; 105: 550-6.
39. Lagneux C, Lamontagne D. Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br J Pharmacol. 2001; 132: 793-6.
40. Bouchard J-F, Lépicier P, Lamontagne D. Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. Life Sci. 2003; 72: 1859-70.
41. Wagner JA, Abesser M, Harvey-White J, Ertl G. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. J Cardiovasc Pharmacol. 2006; 47: 650-5.
42. Ma L, Zhu Z, Zhao Y, Hou L, Wang Q, Xiong L, et al. Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia. Curr Neurovasc Res. 2011; 8: 145-52.
43. Hajrasouliha AR, Tavakoli S, Ghasemi M, Jabehdar-Maralani P, Sadeghipour H, Ebrahimi F, et al. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart. Eur J Pharmacol. 2008; 579: 246-52.
44. Su B, Dong H, Ma R, Zhang X, Ding Q, Xiong L. Cannabinoid 1 receptor mediation of spinal cord ischemic tolerance induced by limb remote ischemia preconditioning in rats. J Thorac Cardiovasc Surg. 2009; 138: 1409-16.
45. Doeuvre L, Plawinski L, Toti F, Angles-Cano E. Cell-derived microparticles: A new challenge in neuroscience. J Neurochem. 2009; 110: 457-68.
46. Kauffman FC, Albuquerque EX. Effect of ischemia and denervation on metabolism of fast and slow mammalian skeletal muscle. Exp Neurol. 1970; 28: 46-63.
47. Strecker T, Messlinger K, Weyand M, Reeh PW. Role of different proton-sensitive channels in releasing calcitonin gene-related peptide from isolated hearts of mutant mice. Cardiovasc Res. 2005; 65: 405-10.
48. Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 2003; 140: 790-801.
49. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A. 2002; 99: 8400-5.
50. Ren C, Yan Z, Wei D, Gao X, Chen X, Zhao H. Limb remote ischemic postconditioning protects against focal ischemia in rats. Brain Res. 2009; 1288: 88-94.
51. Malhotra S, Naggar I, Stewart M, Rosenbaum DM. Neurogenic pathway mediated remote preconditioning protects the brain from transient focal ischemic injury. Brain Res. 2011; 1386: 184-90.
52. Wei D, Ren C, Chen X, Zhao H. The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS One. 2012; 7: e30892.
53. Calvillo L, Vanoli E, Andreoli E, Besana A, Omodeo E, Gnecchi M, et al. Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 2011; 58: 500-7.
54. Katare RG, Ando M, Kakinuma Y, Arikawa M, Handa T, Yamasaki F, et al. Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect. J Thorac Cardiovasc Surg. 2009; 137: 223-31.
55. Mioni C, Bazzani C, Giuliani D, Altavilla D, Leone S, Ferrari A, et al. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med. 2005; 33: 2621-8.
56. Donato M, Buchholz B, Rodriguez M, Perez V, Inserte J, Garcia-Dorado D, et al. Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischemic preconditioning. Exp Physiol. 2012.
57. Basalay M, Barsukevich V, Mastitskaya S, Mrochek A, Pernow J, Sjoquist PO, et al. Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms. Exp Physiol. 2012; 97: 908-17.
58. Mastitskaya S, Marina N, Gourine A, Gilbey MP, Spyer KM, Teschemacher AG, et al. Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc Res. 2012; 95: 487-94.
59. Brzozowski T, Konturek PC, Pajdo R, Kwiecien S, Sliwowski Z, Drozdowicz D, et al. Importance of brain-gut axis in the gastroprotection induced by gastric and remote preconditioning. J Physiol Pharmacol. 2004; 55: 165-77.
60. Addison PD, Neligan PC, Ashrafpour H, Khan A, Zhong A, Moses M, et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol. 2003; 285: H1435-43.
61. Gourine A, Mastitskaya S, Gilbey MP, Ackland GL, gourine AV. Remote preconditioning reflex. European Society of Cardiology Congress Reports. 2010; 1-14.
62. Redington KL, Disenhouse T, Strantzas SC, Gladstone R, Wei C, Tropak MB, et al. Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors. Basic Res Cardiol. 2012; 107: 241.
63. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: Evidence suggesting cross-species protection. Clin Sci. 2009; 117: 191-200.
64. Iadecola C, Anrather J. The immunology of stroke: From mechanisms to translation. Nat Med. 2011; 17: 796-808.
65. Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harbor Perspectives in Biology. 2012
66. Leung PY, Stevens SL, Packard AE, Lessov NS, Yang T, Conrad VK, et al. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke. 2012; 43: 1383-9.
67. Pradillo JM, Fernandez-Lopez D, Garcia-Yebenes I, Sobrado M, Hurtado O, Moro MA, et al. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem. 2009; 109: 287-94.
68. Cho S, Park EM, Zhou P, Frys K, Ross ME, Iadecola C. Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J Cereb Blood Flow Metab. 2005; 25: 493-501.
69. Vartanian K, Stenzel-Poore M. Toll-like receptor tolerance as a mechanism for neuroprotection. Transl Stroke Res. 2010; 1: 252-60.
70. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics. 2004; 19: 143-50.
71. Salanga CL, O'Hayre M, Handel T. Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci. 2009; 66: 1370-86.
72. Weber C. Far from the heart: Receptor cross-talk in remote conditioning. Nat Med. 2010; 16: 760-2.
73. Hasko G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther. 2007; 113: 264-75.
74. Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD. Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol. 2002; 133: 124-31.
75. Klein TW, Cabral GA. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharmacol. 2006; 1: 50-64.
76. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007; 21: 736-45.
77. Andersson U, Tracey KJ. Reflex principles of immunological homeostasis. Annu Rev Immunol. 2012; 30: 313-35.
78. Ottani A, Giuliani D, Mioni C, Galantucci M, Minutoli L, Bitto A, et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J Cereb Blood Flow Metab. 2009; 29: 512-23.
79. Ay I, Lu J, Ay H, Gregory Sorensen A. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci Lett. 2009; 459: 147-51.
80. Sun Z, Baker W, Hiraki T, Greenberg JH. The effect of right vagus nerve stimulation on focal cerebral ischemia: An experimental study in the rat. Brain Stim. 2012; 5: 1-10.
81. Hiraki T, Baker W, Greenberg JH. Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats. J Neurosci Res. 2012; 90: 887-94.
82. Kuriyama N, Mizuno T, Niwa F, Watanabe Y, Nakagawa M. Autonomic nervous dysfunction during acute cerebral infarction. Neurol Res. 2010; 32: 821-7.
83. Chen PL, Kuo TB, Yang CC. Parasympathetic activity correlates with early outcome in patients with large artery atherosclerotic stroke. J Neurol Sci. 2012; 314: 57-61.
84. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325: 612-6.
85. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000; 405: 458-62.
86. Shi FD, Piao WH, Kuo YP, Campagnolo DI, Vollmer TL, Lukas RJ. Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol. 2009; 182: 1730-9.
87. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, Hong SK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J. 1996; 132: 78-83.
88. Zhao Z-Q, Corvera JS, Halkos ME, Kerendi F, Wang N-P, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285: H579-88.
89. Jiang X, Shi E, Nakajima Y, Sato S. Postconditioning, a series of brief interruptions of early reperfusion, prevents neurologic injury after spinal cord ischemia. Ann Surg. 2006; 244: 148-53.
90. Gao X, Ren C, Zhao H. Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res. 2008; 86: 2505-11.
91. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, et al. In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: Ischemic postconditioning. J Cereb Blood Flow Metab. 2008; 28: 232-41.
92. Burda J, Danielisova V, Nemethova M, Gottlieb M, Matiasova M, Domorakova I, et al. Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol. 2006; 26: 1141-51.
93. Domorakova I, Mechirova E, Dankova M, Danielisova V, Burda J. Effect of antioxidant treatment in global ischemia and ischemic postconditioning in the rat hippocampus. Cell Mol Neurobiol. 2009; 29: 837-44.
94. Zhou C, Tu J, Zhang Q, Lu D, Zhu Y, Zhang W, et al. Delayed ischemic postconditioning protects hippocampal CA1 neurons by preserving mitochondrial integrity via Akt/GSK3β signaling. Neurochem Int. 2011; 59: 749-58.
95. Sun J, Tong L, Luan Q, Deng J, Li Y, Li Z, et al. Protective effect of delayed remote limb ischemic postconditioning: role of mitochondrial K(ATP) channels in a rat model of focal cerebral ischemic reperfusion injury. J Cereb Blood Flow Metab. 2012; 32: 851-9.
96. Zhao H, Sapolsky RM, Steinberg GK. Interrupting reperfusion as a stroke therapy: Ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab. 2006; 26: 1114-21.
97. Yao Q-L, Zhang M-F, Wang C-H, Hu F, Lan A-P, Guo R-X, et al. Protective effects of early hypoxic post-conditioning in cultured cortical neurons. Brain Inj. 2011; 25: 604-13.
98. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol. 2005; 100: 57-63.
99. Pateliya BB, Singh N, Jaggi AS. Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull. 2008; 31: 1755-60.
100. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004; 44: 1103-10.
101. Wang Q, Chen Q, Ding Q, Yang Q, Peng Y, Lu Y, et al. Sevoflurane postconditioning attenuates spinal cord reperfusion injury through free radicals-mediated up-regulation of antioxidant enzymes in rabbits. J Surg Res. 2011; 169: 292-300.
102. Rehni AK, Singh TG. Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice. Cytokine. 2012; 60: 83-9.
103. Huang H, Zhang L, Wang Y, Yao J, Weng H, Wu H, et al. Effect of ischemic post-conditioning on spinal cord ischemic-reperfusion injury in rabbits. Can J Anaesth. 2007; 54: 42-8.
104. Jiang X, Ai C, Shi E, Nakajima Y, Ma H. Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: Roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase. Anesthesiology. 2009; 111: 1197-205.
105. Jiang X, Shi E, Li L, Nakajima Y, Sato S. Co-application of ischemic preconditioning and postconditioning provides additive neuroprotection against spinal cord ischemia in rabbits. Life Sci. 2008; 82: 608-14.
106. Jones NM, Bergeron M. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J Neurochem. 2004; 89: 157-67.
107. Kumral A, Tuzun F, Ozbal S, Ugur Ergur B, Yilmaz O, Duman N, et al. Lipopolysaccharide-preconditioning protects against endotoxin-induced white matter injury in the neonatal rat brain. Brain Res. 2012; 1489: 81-9.
108. Dewar D, Yam P, McCulloch J. Drug development for stroke: Importance of protecting cerebral white matter. Eur J Pharmacol. 1999; 375: 41-50.
109. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: Lessons from animal models. Metab Brain Dis. 2004; 19: 151-67.
110. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 1999; 22: 391-7.
111. Ginsberg MD. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology. 2008; 55: 363-89.
112. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1, 026 experimental treatments in acute stroke. Ann Neurol. 2006; 59: 467-77.
113. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010; 121: 948-54.
114. Auriel E, Bornstein NM. Neuroprotection in acute ischemic stroke-current status. J Cell Mol Med. 2010; 14: 2200-2.
115. Donnan GA. The 2007 Feinberg lecture: A new road map for neuroprotection. Stroke. 2008; 39: 242.
116. Feuerstein GZ, Chavez J. Translational medicine for stroke drug discovery: The pharmaceutical industry perspective. Stroke. 2009; 40: S121-5.
117. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009; 40: 2244-50.
118. Hallenbeck JM, Frerichs KU. Stroke therapy. It may be time for an integrated approach. Arch Neurol. 1993; 50: 768-70.
119. Hallenbeck J, Frerichs KU. Secondary ischemic neuronal damage may involve multiple factors acting as an Aagregate of minor causes. In: Robertson JT, Nowak Jr TS, editors. Frontiers in cerebrovascular disease: Mechanisms, diagnosis, and treatment. Armonk, NY: Futura Publishing Company, Inc.; 1998. p. 95-101.
120. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011; 42: 2645-50.
121. Iadecola C, Anrather J. Stroke research at a crossroad: Asking the brain for directions. Nat Neurosci. 2011; 14: 1363-8.
122. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem. 2004; 89: 73-89.
123. Lu A, Tang Y, Ran R, Clark JF, Aronow BJ, Sharp FR. Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab. 2003; 23: 786-810.
124. Stapels M, Piper C, Yang T, Li M, Stowell C, Xiong ZG, et al. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci Signal. 2010; 3: ra15.
125. Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: A speculative synthesis. Stroke. 2007; 38: 680-5.
126. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995; 333: 1581-7.
127. Garcia-Dorado D, Barba I, Inserte J. Twenty-five years of preconditioning: Are we ready for ischaemia? From coronary occlusion to systems biology and back. Cardiovasc Res. 2011; 91: 378-81.
128. Hoda MN, Siddiqui S, Herberg S, Periyasamy-Thandavan S, Bhatia K, Hafez SS, et al. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke. 2012; 43: 2794-9.
129. Przytycka TM, Kim YA. Network integration meets network dynamics. BMC Biol. 2010; 8: 48.
130. Tropak MB, Shi H, Li J, Dai X, Redington AN, Askalan R. Potent neuroprotection induced by remote preconditioning in a rat model of neonatal cerebral hypoxic-ischemic injury. J Thorac Cardiovasc Surg. 2011; 142: 233-5.
131. Dave KR, Saul I, Prado R, Busto R, Perez-Pinzon MA. Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest. Neurosci Lett. 2006; 404: 170-5.
132. Zhao H-G, Li W-B, Li Q-J, Chen X-L, Liu H-Q, Feng R-F, et al. Limb ischemic preconditioning attenuates apoptosis of pyramidal neurons in the CA1 hippocampus induced by cerebral ischemia-reperfusion in rats. Sheng Li xue Bao [Acta Physiologica Sinica]. 2004; 56: 407-12.
133. Jin RL, Li WB, Li QJ, Zhang M, Xian XH, Sun XC, et al. The role of extracellular signal-regulated kinases in the neuroprotection of limb ischemic preconditioning. Neurosci Res. 2006; 55: 65-73.
134. Saxena P, Bala A, Campbell K, Meloni B. d'Udekem Y, Konstantinov IE. Does remote ischemic preconditioning prevent delayed hippocampal neuronal death following transient global cerebral ischemia in rats? Perfusion. 2009; 24: 207-11.
135. Ren C, Gao X, Steinberg GK, Zhao H. Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience. 2008; 151: 1099-103.
136. Rehni AK, Shri R, Singh M. Remote ischaemic preconditioning and prevention of cerebral injury. Indian J Exp Biol. 2007; 45: 247-52.
137. Jensen HA, Loukogeorgakis S, Yannopoulos F, Rimpilainen E, Petzold A, Tuominen H, et al. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation. 2011; 123: 714-21.
138. Yannopoulos FS, Makela T, Niemela E, Tuominen H, Lepola P, Alestalo K, et al. Improved cerebral recovery from hypothermic circulatory arrest after remote ischemic preconditioning. Ann Thorac Surg. 2010; 90: 182-8.
139. Gurcun U, Discigil B, Boga M, Ozkisacik E, Badak MI, Yenisey C, et al. Is remote preconditioning as effective as direct ischemic preconditioning in preventing spinal cord ischemic injury? J Surg Res. 2006; 135: 385-93.
140. Geng X, Ren C, Wang T, Fu P, Luo Y, Liu X, et al. Effect of remote ischemic postconditioning on an intracerebral hemorrhage stroke model in rats. Neurol Res. 2012; 34: 143-8.
141. Ren C, Gao M, Dornbos D, Ding Y, Zeng X, Luo Y, et al. Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury. Neurol Res. 2011; 33: 514-9.
142. Peng B, Guo Q-L, He Z-J, Ye Z, Yuan Y-J, Wang N, et al. Remote ischemic postconditioning protects the brain from global cerebral ischemia/reperfusion injury by up-regulating endothelial nitric oxide synthase through the PI3K/Akt pathway. Brain Res. 2012; 1445: 92-102.
143. Wang Q, Zhang X, Ding Q, Hu B, Xie Y, Li X, et al. Limb remote postconditioning alleviates cerebral reperfusion injury through reactive oxygen species-mediated inhibition of delta protein kinase C in rats. Anesth Analg. 2011; 113: 1180-7.
144. Ye Z, Guo Q, Xia P, Wang N, Wang E, Yuan Y. Sevoflurane postconditioning involves an up-regulation of HIF-1α and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia. Brain Res. 2012; 1463: 63-74.
145. Adamczyk S, Robin E, Simerabet M, Kipnis E, Tavernier B, Vallet B, et al. Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth. 2010; 104: 191-200.
146. Fang Li Q, Xu H, Sun Y, Hu R, Jiang H. Induction of inducible nitric oxide synthase by isoflurane post-conditioning via hypoxia inducible factor-1α during tolerance against ischemic neuronal injury. Brain Res. 2012; 1451: 1-9.
147. Wang JK, Yu LN, Zhang FJ, Yang MJ, Yu J, Yan M, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res. 2010; 1357: 142-51.
148. Zhang Y, Zhang F-G, Meng C, Tian S-Y, Wang Y-X, Zhao W, et al. Inhibition of sevoflurane postconditioning against cerebral ischemia reperfusion-induced oxidative injury in rats. Molecules. 2012; 17: 341-54.
149. Lee HM, Lee DH, Choi JH, Lee SR, Kim YW, Jee DL, et al. Sevoflurane-induced post-conditioning has no beneficial effects on neuroprotection after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand. 2010; 54: 328-36.
150. Danielisova V, Gottlieb M, Nemethova M, Kravcukova P, Domorakova I, Mechirova E, et al. Bradykinin postconditioning protects pyramidal CA1 neurons against delayed neuronal death in rat hippocampus. Cell Mol Neurobiol. 2009; 29: 871-8.
151. Danielisova V, Gottlieb M, Nemethova M, Burda J. Effects of bradykinin postconditioning on endogenous antioxidant enzyme activity after transient forebrain ischemia in rat. Neurochem Res. 2008; 33: 1057-64.
152. Nagy D, Kocsis K, Fuzik J, Marosi M, Kis Z, Teichberg VI, et al. Kainate postconditioning restores LTP in ischemic hippocampal CA1: Onset-dependent second pathophysiological stress. Neuropharmacology. 2011; 61: 1026-32.
153. Yang YW, Lu JK, Qing EM, Dong XH, Wang CB, Zhang J, et al. Post-conditioning by xenon reduces ischaemia-reperfusion injury of the spinal cord in rats. Acta Anaesthesiol Scand. 2012; 56: 1325-31.
154. Leconte C, Tixier E, Freret T, Toutain J, Saulnier R, Boulouard M, et al. Delayed hypoxic postconditioning protects against cerebral ischemia in the mouse. Stroke. 2009; 40: 3349-55.
155. Zhan L, Li D, Liang D, Wu B, Zhu P, Wang Y, et al. Activation of Akt/FoxO and inactivation of MEK/ERK pathways contribute to induction of neuroprotection against transient global cerebral ischemia by delayed hypoxic postconditioning in adult rats. Neuropharmacology. 2012; 63: 873-82.
156. Rybnikova E, Vorobyev M, Pivina S, Samoilov M. Postconditioning by mild hypoxic exposures reduces rat brain injury caused by severe hypoxia. Neurosci Lett. 2012; 513: 100-5.
157. Davis AEM, Campbell SJ, Wilainam P, Anthony DC. Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: A potential neuroprotective treatment. Eur J Neurosci. 2005; 22: 2441-50.
158. Kaur H, Jaggi AS, Singh N. Modulation of neuroprotective effect of ischemic post-conditioning by dichlorobenzamil a Na(+)/Ca(2+) exchanger inhibitor in mice. Biol Pharm Bull. 2010; 33: 585-91.
159. Rehni AK, Bhateja P, Singh N. Diethyl dithiocarbamic acid, a possible nuclear factor kappa B inhibitor, attenuates ischemic postconditioning-induced attenuation of cerebral ischemia-reperfusion injury in mice. Can J Physiol Pharmacol. 2009; 87: 63-8.
160. Rehni AK, Singh N. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep. 2007; 59: 192-8.
161. Ding Z-M, Wu B, Zhang W-Q, Lu X-J, Lin Y-C, Geng Y-J, et al. Neuroprotective effects of ischemic preconditioning and postconditioning on global brain ischemia in rats through the same effect on inhibition of apoptosis. Int J Mol Sci. 2012; 13: 6089-101.
162. Wang JY, Shen J, Gao Q, Ye ZG, Yang SY, Liang HW, et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke. 2008; 39: 983-90.
163. Zhang W, Wang B, Zhou S, Qiu Y. The effect of ischemic post-conditioning on hippocampal cell apoptosis following global brain ischemia in rats. J Clin Neurosci. 2012; 19: 570-3.
164. Zhang W, Miao Y, Zhou S, Wang B, Luo Q, Qiu Y. Involvement of glutamate transporter-1 in neuroprotection against global brain ischemia-reperfusion injury induced by postconditioning in rats. Int J Mol Sci. 2010; 11: 4407-16.
165. Ren C, Gao X, Niu G, Yan Z, Chen X, Zhao H. Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One. 2008; 3: e3851.
166. Yuan Y, Guo Q, Ye Z, Pingping X, Wang N, Song Z. Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway. Brain Res. 2011; 1367: 85-93.
167. Abas F, Alkan T, Goren B, Taskapilioglu O, Sarandol E, Tolunay S. Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats. Turk Neurosurg. 2010; 20: 1-8.
168. Kim YK, Leem JG, Shin JW, Joung KW. Ischemic postconditioning may not influence early brain injury induced by focal cerebral ischemia/reperfusion in rats. Korean J Anesthesiol. 2010; 58: 176-83.
169. 2+ exchanger contributes to neuroprotection elicited by ischemic postconditioning. J Cereb Blood Flow Metab. 2011; 31: 362-70.
170. Robin E, Simerabet M, Hassoun SM, Adamczyk S, Tavernier B, Vallet B, et al. Postconditioning in focal cerebral ischemia: Role of the mitochondrial ATP-dependent potassium channel. Brain Res. 2011; 1375: 137-46.
171. Sun J, Luan Q, Dong H, Song W, Xie K, Hou L, et al. Inhibition of mitochondrial permeability transition pore opening contributes to the neuroprotective effects of ischemic postconditioning in rats. Brain Res. 2012; 1436: 101-10.
172. Taskapilioglu MO, Alkan T, Goren B, Tureyen K, Sahin S, Taskapilioglu O, et al. Neuronal protective effects of focal ischemic pre- and/or postconditioning on the model of transient focal cerebral ischemia in rats. J Clin Neurosci. 2009; 16: 693-7.
173. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke. 2008; 39: 2362-9.
174. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, et al. Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem. 2008; 105: 1737-45.